• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS HEMOGLOBIN A1C GEN.2; ASSAY, GLYCOSYLATED HEMOGLOBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS HEMOGLOBIN A1C GEN.2; ASSAY, GLYCOSYLATED HEMOGLOBIN Back to Search Results
Catalog Number 05401640190
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/18/2016
Event Type  malfunction  
Manufacturer Narrative
It was asked, but it is not known in which country this event occurred.
 
Event Description
The customer reported that they received questionable results for approximately six patient samples tested for tina-quant hemoglobin a1c gen.2 (hba1c) on a c111 analyzer.The customer loaded a new hba1c reagent kit on the analyzer and initially tested the patient samples.Patient values were said to be either too high or too low.The samples were repeated after the reagent kit was replaced and calibrated.Of the six patient samples, two were found to have erroneous hba1c results.It was stated that none of the erroneous results were reported to the patient.It was not clear if any erroneous results were reported outside of the laboratory.A clarification has been requested.The first sample initially resulted as 4.8%.After the reagent kit was replaced, the sample was repeated, resulting as 6.69%.The second sample initially resulted as 7.0%.The sample was repeated outside of the laboratory on a different analyzer, resulting as 9.0%.After the reagent kit was replaced on the original analyzer, the sample was repeated again, resulting as 8.9%.The patients were not adversely affected.The c111 analyzer serial number was (b)(4).It was stated that the customer was not running quality controls and that they were doing weekly interlab comparisons with hba1c hplc method.The customer stated that they did not have any further issues after replacing the reagent cassette.
 
Manufacturer Narrative
A specific root cause could not be determined based on the provided information.Additional information required for the investigation was requested, but not provided.A reagent issue can be excluded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMOGLOBIN A1C GEN.2
Type of Device
ASSAY, GLYCOSYLATED HEMOGLOBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5430224
MDR Text Key38015649
Report Number1823260-2016-00138
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
PMA/PMN Number
K072714
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 03/16/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2016
Device Catalogue Number05401640190
Device Lot Number610611-01
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/18/2016
Initial Date FDA Received02/11/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/16/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-